autologous monocyte-derived lysate-pulsed dendritic cells PV-001-DC
Term · Oncology and biomedicine · MLC-T-ONC-011701
A cell-based cancer vaccine composed of autologous, monocyte-derived dendritic cells (mDCs) pulsed with tumor cell lysate containing tumor associated antigens (TAAs), with potential immunostimulatory and antineoplastic activities. Upon administration,the autologous tumor cell lysate-pulsed mDCs vaccine PV-001-DC may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the patient's tumor cell-specific TAAs, which may result in tumor cell lysis.
| Identifier | MLC-T-ONC-011701 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous monocyte-derived lysate pulsed DCs PV-001-DC; PV-001-dendritic cell |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011701",
"term": "autologous monocyte-derived lysate-pulsed dendritic cells PV-001-DC",
"field": "Oncology and biomedicine",
"definition": "A cell-based cancer vaccine composed of autologous, monocyte-derived dendritic cells (mDCs) pulsed with tumor cell lysate containing tumor associated antigens (TAAs), with potential immunostimulatory and antineoplastic activities. Upon administration,the autologous tumor cell lysate-pulsed mDCs vaccine PV-001-DC may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the patient's tumor cell-specific TAAs, which may result in tumor cell lysis.",
"synonyms": [
"autologous monocyte-derived lysate pulsed DCs PV-001-DC",
"PV-001-dendritic cell"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-monocyte-derived-lysate-pulsed-dendritic-cells-pv-001-dc/"
}
Record 3,037 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.